control group:hydration

4 trials

Sponsors

Taizhou First People's Hospital, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Dongguan People's Hospital, Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Conditions

Contrast induced nephropathyContrast-induced Nephropathycontrast nephropathycoronary heart disease complicated with moderate renal impairment

Early Phase 1

Hemofiltration for prevention of contrast-induced nephropathy after PCI in patients with coronary heart disease complicated with moderate renal impairment:a randomized, controlled, single-center study

Active, not recruitingChiCTR2200057255

Nanjing Drum Tower Hospital, Medical School of Nanjing Universitycoronary heart disease complicated with moderate renal impairment

Start: 2022-03-15Updated: 2023-10-09

Phase 4

Effect of nicorandil on the prevention of contrast nephropathy in patients with coronary heart disease undergoing interventional therapy

Active, not recruitingChiCTR2200064264

Dongguan People's Hospitalcontrast nephropathy

Start: 2022-10-01Updated: 2023-05-15

Unknown Phase

Prevention of Contrast-Induced Nephropathy with Prostaglandin E1 in Diabetic Patients Undergoing Percutaneous Transluminal Angioplasty: A Randomized, Placebo-Controlled Study

Active, not recruitingChiCTR-PRC-13003922

Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityContrast induced nephropathy

Start: 2013-01-01Updated: 2017-04-18

Combined use of hydration and reduced glutathione for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients with diabetes

Active, not recruitingChiCTR1900028664

Taizhou First People's HospitalContrast-induced Nephropathy

Start: 2016-08-01Updated: 2020-01-06